Genomic Health, Inc (GHDX) Covered Calls

Genomic Health, Inc covered calls Genomic Health, Inc. is engaged in the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions.

You can sell covered calls on Genomic Health, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for GHDX (prices last updated Wed 4:16 PM ET):

Genomic Health, Inc (GHDX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
83.66 +1.02 84.00 90.00 355K 165 3.0B
Covered Calls For Genomic Health, Inc (GHDX)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Mar 15 85 3.40 86.60 -1.8% -27.4%
Apr 18 85 5.00 85.00 0.0% 0.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Genomic Health, Inc. is a global healthcare company that provides actionable genomic information to personalize cancer treatment decisions. The company has a robust pipeline focused on developing tests to optimize the treatment of renal cell cancers, as well as additional treatment decisions in breast and colon cancers. It is dedicated to addressing the difficult challenges of cancer treatment by utilizing genomics to help physicians and patients choose the most appropriate treatment options with optimal confidence. Genomic Health was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott and Steven Shak in August 2000 and is headquartered in Redwood City, CA.